Filing Details
- Accession Number:
- 0001131096-14-000031
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-07-11 16:21:44
- Reporting Period:
- 2014-07-10
- Filing Date:
- 2014-07-11
- Accepted Time:
- 2014-07-11 16:21:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1131096 | Athenahealth Inc | ATHN | Services-Business Services, Nec (7389) | 043387530 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1210881 | Robert Cosinuke | C/O Athenahealth, Inc 311 Arsenal Street Watertown MA 02472 | Svp, Chief Marketing Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-07-10 | 6,000 | $35.26 | 50,804 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-07-10 | 2,456 | $119.30 | 48,348 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-07-10 | 2,500 | $120.45 | 45,848 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-07-10 | 1,044 | $121.14 | 44,804 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-07-10 | 6,000 | $0.00 | 6,000 | $35.26 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 15,000 | 2008-12-03 | 2018-01-02 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on February 12, 2013, in accordance with Rule 10b5-1
- This price represents the weighted average of sales ranging from $119.02 to $119.97. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average of sales ranging from $120.07 to $120.92. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average of sales ranging from $121.00 to $121.21. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
